SG10201710601YA - A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions - Google Patents
A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositionsInfo
- Publication number
- SG10201710601YA SG10201710601YA SG10201710601YA SG10201710601YA SG10201710601YA SG 10201710601Y A SG10201710601Y A SG 10201710601YA SG 10201710601Y A SG10201710601Y A SG 10201710601YA SG 10201710601Y A SG10201710601Y A SG 10201710601YA SG 10201710601Y A SG10201710601Y A SG 10201710601YA
- Authority
- SG
- Singapore
- Prior art keywords
- freeze
- cells
- encapsulated cells
- compositions
- dried
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- 238000004108 freeze drying Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/128—Chemically defined matrices for immobilising, holding or storing living parts, e.g. alginate gels; Chemically altering living parts, e.g. by cross-linking
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
- C12N11/12—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13174681 | 2013-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201710601YA true SG10201710601YA (en) | 2018-02-27 |
Family
ID=48700437
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510671SA SG11201510671SA (en) | 2013-07-02 | 2014-07-02 | A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions |
| SG10201710601YA SG10201710601YA (en) | 2013-07-02 | 2014-07-02 | A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201510671SA SG11201510671SA (en) | 2013-07-02 | 2014-07-02 | A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10329526B2 (en) |
| EP (1) | EP3016511B1 (en) |
| JP (1) | JP6643984B2 (en) |
| KR (1) | KR102250588B1 (en) |
| CN (1) | CN105517434B (en) |
| AU (1) | AU2014286177B2 (en) |
| BR (1) | BR112015032918B1 (en) |
| CA (1) | CA2917109C (en) |
| DK (1) | DK3016511T3 (en) |
| ES (1) | ES2763968T3 (en) |
| PH (1) | PH12015502860B1 (en) |
| SG (2) | SG11201510671SA (en) |
| WO (1) | WO2015000972A1 (en) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20131467A1 (en) * | 2013-09-06 | 2015-03-07 | Sofar Spa | USE OF A COMPOSITION INCLUDING MICRO-ORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTIRRIC ACID, FOLIC ACID OR NIACINE ACID AND / OR TO REDUCE THE INTESTINAL PRODUCTION OF SUCCINIC ACID |
| MA39710A (en) | 2014-04-23 | 2015-10-29 | Sofar Spa | Topical composition for use in the treatment of inflammatory bowel disease |
| GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
| CN104830689A (en) * | 2015-05-26 | 2015-08-12 | 固元本草汉方生物科技股份有限公司 | Lactic acid bacteria freeze-drying protecting agent |
| KR101845715B1 (en) * | 2015-06-03 | 2018-04-05 | (주)제노텍 | Composition of Anti-freezing agents |
| MA41060B1 (en) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| LT6463B (en) | 2015-12-10 | 2017-10-10 | Uab "Probiosanus" | Increase of survival and stabilization of probiotic bacteria (pb) in detergent based compositions of personal hygiene and hausehold care products |
| US9999640B2 (en) | 2016-02-02 | 2018-06-19 | University Of Dammam | Microencapsulated probiotic bacteria |
| US10806769B2 (en) | 2016-03-31 | 2020-10-20 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| CA3018866C (en) | 2016-03-31 | 2024-03-26 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| BE1024197B1 (en) * | 2016-05-02 | 2017-12-13 | Lacto Research Sprl | Process for coating microorganisms, powder of said coated microorganisms obtained and pharmaceutical, nutraceutical, cosmetic, food or sanitary composition comprising it. |
| MA45327A (en) | 2016-05-13 | 2019-03-20 | Sofar Spa | USE OF PROBIOTICS TO IMPROVE PROTEIN ABSORPTION |
| MA45288A (en) | 2016-06-08 | 2019-04-17 | Sofar Spa | New medical use of probiotics |
| BE1023757B1 (en) * | 2016-06-30 | 2017-07-12 | Yun NV | STORAGE OF MICRO-ORGANISMS |
| RU2762607C2 (en) | 2016-09-13 | 2021-12-21 | Аллерган, Инк. | Stabilized non-protein compositions of clostridial toxin |
| TWI670371B (en) | 2016-10-04 | 2019-09-01 | 全崴生技股份有限公司 | Compositions and methods for cell cryopreservation |
| CN106538512B (en) * | 2016-10-08 | 2019-07-30 | 北京汉氏联合干细胞研究院有限公司 | A kind of active stem cell gel preparation of holding freeze-stored cell and its application |
| EP3544575A1 (en) | 2016-11-23 | 2019-10-02 | GOJO Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| IT201600122724A1 (en) | 2016-12-02 | 2018-06-02 | Sofar Spa | EXOPOLYSACCHARIDES AND USES THEREOF |
| DK3335695T3 (en) * | 2016-12-15 | 2020-04-20 | Upm Kymmene Corp | Process for freeze-drying hydrogel comprising nanofibrillar cellulose, freeze-dried medical hydrogel comprising nanofibrillar cellulose and hydrogel comprising nanofibrillar cellulose |
| IT201600127498A1 (en) | 2016-12-16 | 2018-06-16 | Sofar Spa | PROBIOTICS FOR USE IN DIVERTICULOSIS AND DIVERTICULAR DISEASE |
| AU2018215216B2 (en) | 2017-01-31 | 2024-04-18 | Axiota U.S., Inc. | Microbial cells, methods of producing the same, and uses thereof |
| US11191791B2 (en) * | 2017-02-22 | 2021-12-07 | Praj Industries Limited | Preparation of dry formulations of dairy probiotics |
| US20220125042A1 (en) * | 2017-05-17 | 2022-04-28 | Universidade Nova De Lisboa | Cryoprotectant and/or cryopreservant composition, methods and uses thereof |
| WO2018227359A1 (en) * | 2017-06-13 | 2018-12-20 | Chung Chin Sun | A novel method for blood serum protein activity preservation |
| UY37944A (en) | 2017-10-20 | 2019-05-31 | Ms Biotech Inc | METHODS TO PRODUCE VEGETABLE MATERIALS SHIELDED USING MEGASPHAERA ELSDENII |
| CN111432804A (en) * | 2017-11-27 | 2020-07-17 | 帝斯曼知识产权资产管理有限公司 | Lyophilized multiparticulate solid dosage forms |
| CN109295182A (en) * | 2018-09-30 | 2019-02-01 | 苏州百源基因技术有限公司 | A kind of PCR dispenses the reaction tube of reagent and prepackage PCR reagent in advance |
| US20210348153A1 (en) * | 2018-10-04 | 2021-11-11 | Technion Research & Development Foundation Limited | Cellulose-encapsulated oil emulsions and methods for cellulase regeneration |
| US20220090046A1 (en) * | 2019-01-25 | 2022-03-24 | The Australian National University | Encapsulated Cells |
| US11968975B2 (en) * | 2019-04-30 | 2024-04-30 | Regents Of The University Of Minnesota | Compositions and methods for storing liquid biospecimens |
| US20220338463A1 (en) * | 2019-09-13 | 2022-10-27 | Lonza Ltd | Method of producing lyophilized cells |
| CA3151326A1 (en) * | 2019-09-16 | 2021-03-25 | Scott MICHONSKI | Methods and compositions for preserving bacteria |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| US20240261347A1 (en) * | 2020-01-31 | 2024-08-08 | ProAgni Pty Ltd | Probiotic formulation and delivery |
| CO2020006220A1 (en) | 2020-05-21 | 2020-11-30 | Bialtec Sas | Formulations of functional additives and their encapsulation process |
| CN111534434B (en) * | 2020-06-28 | 2022-07-05 | 江南大学 | A freeze-dried protective agent and its application in freeze-dried Bifidobacterium adolescentis |
| US12453805B2 (en) | 2020-09-24 | 2025-10-28 | Everest Medical Innovation GmbH | Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery |
| US12426594B2 (en) | 2020-09-24 | 2025-09-30 | Everest Medical Innovation GmbH | Cryoprotective compositions and methods for protection of a surgical site during cryosurgery |
| KR20230104155A (en) * | 2020-10-14 | 2023-07-07 | 덤바이온트, 인코포레이티드 | Compositions and methods for improving skin health and treating and preventing diseases, disorders and conditions associated with fungi and other pathogenic microorganisms |
| KR102490870B1 (en) * | 2021-01-18 | 2023-01-20 | 씨제이제일제당 주식회사 | Composition for cryopreservation of microalgae of Thraustochytriaceae and method for cryopreservation of the microalgae of Thraustochytriaceae using thereof |
| CN112999198A (en) * | 2021-03-10 | 2021-06-22 | 中农宠物营养研究院(江苏)有限公司 | Synbiotic microcapsule capable of resisting gastric acid and achieving intestinal tract targeted release based on chitosan-Fe coating and preparation method thereof |
| AU2022231891A1 (en) | 2021-03-12 | 2023-09-14 | Société des Produits Nestlé S.A. | Gos pre-conditioning lactobacillus strains and gos in final formulation |
| EP4056053A1 (en) | 2021-03-12 | 2022-09-14 | Biogaia AB | Pre-conditioning of l. reuteri |
| EP4056052A1 (en) | 2021-03-12 | 2022-09-14 | Biogaia AB | Gos pre-conditioning l. reuteri and gos in final formulation |
| CN113621519B (en) * | 2021-08-11 | 2023-07-18 | 河南农业大学 | A compound yeast freeze-drying protectant |
| WO2023080281A1 (en) * | 2021-11-05 | 2023-05-11 | 주식회사 프롬바이오 | Cell cryopreservation composition using pectin and alanine and cell cryopreservation method using same |
| CN114292788A (en) * | 2021-12-30 | 2022-04-08 | 江苏德禧生物科技有限公司 | Preparation method of active probiotics by freeze drying |
| CN114451485B (en) * | 2022-01-26 | 2022-12-30 | 江苏省淡水水产研究所 | Traditional Chinese medicine polysaccharide extract freeze-drying protective agent, direct-vat-set starter and preparation method thereof |
| WO2023201258A2 (en) * | 2022-04-12 | 2023-10-19 | Avenge Bio, Inc. | Encapsulated cells and methods of preserving thereof |
| CN115024310B (en) * | 2022-07-19 | 2024-06-18 | 首都医科大学宣武医院 | A cell freeze-dried preservative and preparation method thereof |
| CN116784452A (en) * | 2023-05-04 | 2023-09-22 | 河北同福健康产业有限公司 | A kind of old noodle steamed bun compound fermentation bacteria and its preparation method |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5071741A (en) * | 1988-04-18 | 1991-12-10 | Cryolife, Inc. | Cryoprotective agent and its use in cryopreservation of cellular matter |
| US5217860A (en) * | 1991-07-08 | 1993-06-08 | The American National Red Cross | Method for preserving organs for transplantation by vitrification |
| US5518878A (en) | 1993-09-15 | 1996-05-21 | Organogenesis Inc. | Cryopreservation of cultured skin or cornea equivalents with agitation |
| US5595866A (en) * | 1994-05-27 | 1997-01-21 | Methodist Hospital Of Indiana, Inc. | Step-wise method to remove cryoprotectant from sperm |
| JP2002000248A (en) | 2000-06-23 | 2002-01-08 | Daiichi Kagaku Kk | Freezing method and freeze-drying method |
| US20060246414A1 (en) * | 2005-04-28 | 2006-11-02 | Livestock Research Institute, Council Of Agriculture | Method for microdrop vitrification of cells |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| CA2743641C (en) * | 2008-11-14 | 2024-03-26 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| CN102481322A (en) | 2009-05-01 | 2012-05-30 | 微制药有限公司 | Bacterial compositions for prophylaxis and treatment of degenerative disease |
| US20100311036A1 (en) | 2009-06-09 | 2010-12-09 | University Of South Carolina | Methods for Augmentation of Cell Cryopreservation |
| PH12013501530A1 (en) | 2011-01-25 | 2013-09-16 | Austrianova Singapore Pte Ltd | Protection of microbial cells from acidic degradation |
| AU2012349340B2 (en) * | 2011-12-07 | 2015-11-05 | Asahi Group Holdings, Ltd. | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof |
| CN102586148B (en) * | 2012-02-28 | 2013-05-08 | 江南大学 | Plant lactobacillus capable of relieving lead toxicity and application thereof |
-
2014
- 2014-07-02 CN CN201480047959.9A patent/CN105517434B/en active Active
- 2014-07-02 DK DK14744005.1T patent/DK3016511T3/en active
- 2014-07-02 SG SG11201510671SA patent/SG11201510671SA/en unknown
- 2014-07-02 AU AU2014286177A patent/AU2014286177B2/en active Active
- 2014-07-02 BR BR112015032918-7A patent/BR112015032918B1/en active IP Right Grant
- 2014-07-02 US US14/902,539 patent/US10329526B2/en active Active
- 2014-07-02 JP JP2016522603A patent/JP6643984B2/en active Active
- 2014-07-02 WO PCT/EP2014/064087 patent/WO2015000972A1/en not_active Ceased
- 2014-07-02 KR KR1020167002913A patent/KR102250588B1/en active Active
- 2014-07-02 SG SG10201710601YA patent/SG10201710601YA/en unknown
- 2014-07-02 EP EP14744005.1A patent/EP3016511B1/en active Active
- 2014-07-02 ES ES14744005T patent/ES2763968T3/en active Active
- 2014-07-02 CA CA2917109A patent/CA2917109C/en active Active
-
2015
- 2015-12-23 PH PH12015502860A patent/PH12015502860B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ716212A (en) | 2021-05-28 |
| KR102250588B1 (en) | 2021-05-12 |
| AU2014286177A1 (en) | 2016-02-18 |
| CA2917109C (en) | 2022-11-01 |
| CA2917109A1 (en) | 2015-01-08 |
| JP6643984B2 (en) | 2020-02-12 |
| ES2763968T3 (en) | 2020-06-01 |
| CN105517434A (en) | 2016-04-20 |
| BR112015032918A8 (en) | 2019-12-24 |
| AU2014286177B2 (en) | 2018-01-18 |
| PH12015502860B1 (en) | 2019-10-02 |
| PH12015502860A1 (en) | 2016-03-28 |
| EP3016511B1 (en) | 2019-10-09 |
| US10329526B2 (en) | 2019-06-25 |
| KR20160033129A (en) | 2016-03-25 |
| US20160298077A1 (en) | 2016-10-13 |
| WO2015000972A1 (en) | 2015-01-08 |
| JP2016524900A (en) | 2016-08-22 |
| EP3016511A1 (en) | 2016-05-11 |
| BR112015032918B1 (en) | 2021-09-28 |
| DK3016511T3 (en) | 2020-01-13 |
| SG11201510671SA (en) | 2016-01-28 |
| CN105517434B (en) | 2019-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201510671SA (en) | A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions | |
| IL285390A (en) | Arylquinazolines, their preparation and pharmaceutical compositions containing them | |
| EP2970595A4 (en) | High purity lignin, lignin compositions, and higher structured lignin | |
| IL247516A0 (en) | Nanocrystaline cellulose as absorbent and encapsulation material | |
| PL2868206T3 (en) | Microparticles for the encapsulation of probiotics, preparation and uses thereof | |
| ZA201505966B (en) | Peptides and compositions | |
| SG10201709161SA (en) | Novel polymer and thermosetting composition containing same | |
| SG11201506984UA (en) | Cosmetic composition comprising powder and production method therefor | |
| IL241439A0 (en) | Compositions and methods for modulating tau expression | |
| EP2984186A4 (en) | Method of converting lignin and uses thereof | |
| GB201321693D0 (en) | Composition and uses thereof | |
| PT3062820T (en) | Methods for encapsulation and microcapsules produced thereby | |
| EP2997090A4 (en) | Single pellet polymeric compositions | |
| EP3048928A4 (en) | Capsule cosmetics and manufacturing method thereof | |
| IL246299A0 (en) | Survivin derivatives and compositions containing them | |
| ZA201505602B (en) | Composition comprising an encapsulated antagomir | |
| GB201401930D0 (en) | Plant protection composition and method | |
| IL276126B (en) | Compositions comprising l-4-chlorokynurenine and uses thereof | |
| GB201301457D0 (en) | Freeze-dried composition | |
| GB201322456D0 (en) | Radiotracer compositions and methods | |
| EP2943575A4 (en) | Enzyme production compositions and methods | |
| EP2964610A4 (en) | Vinylsulfone-based 18f-labeling compositions and methods and uses thereof | |
| PT3066199T (en) | Snorna, compositions and uses | |
| SG11201507540WA (en) | Encapsulation of active ingredients and method of making | |
| GB2518694B (en) | Enabling encapsulation in networks |